Asia Pacific PoC Diagnostics Market by Products (Cardiac Markers, Infectious Disease Testing, OTC and Rapid Diagnostics, Coagulation) to Reach USD 5,427.1 Million by 2020

Market Size - $ 2,967.69 mn in 2013, Market Growth - CAGR of 8.9%, Market Trends – Growing demand for decentralized healthcare. View complete report: http://www.grandviewresearch.com/industry-analysis/asia-pacific-poc-diagnostics-market.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInShare on PinterestEmail a friend

Grand View Research

Growing prevalence of infectious and cardiovascular diseases, diabetes and cancer coupled with constantly improving healthcare infrastructure is expected to drive market growth over the next six years

San Francisco, California (PRWEB) April 09, 2014

The Asia Pacific market for point of care (PoC) diagnostics is expected to reach USD 5,427.1 million by 2020, according to a new study by Grand View Research, Inc. Growing base of geriatric population and the ability to render immediate results and improve patient care coupled with rising market penetration of PACS (picture archiving and communication systems) and EMR (electronic medical records) are expected to drive demand over the next six years. Skilled staff shortages, especially pertaining to the field of diagnostics are also expected to accelerate the market penetration rates of PoC products, by expediting lab automation processes. Rising demand for home healthcare and other healthcare establishments catering to the elderly population and initiatives undertaken by governments to shorten hospital stays by establishing out-patient care models are also expected to be key market factors.

The rapidly growing use of point of care diagnostic products has introduced a decentralization trend in the overall healthcare industry. Healthcare facilities and patients, in an attempt to attain or cater medical facilities remotely, encourage early diagnosis, and curb costs are now decentralizing their facilities. Furthermore, these trends have also triggered the establishment of remote and stand alone diagnostic facilities.

The report “Asia Pacific PoC Diagnostics Market Analysis And Segment Forecasts To 2020” is available now to Grand View Research customers at http://www.grandviewresearch.com/industry-analysis/asia-pacific-poc-diagnostics-market.

Inquire Before Buying @ http://www.grandviewresearch.com/inquiry/332.

Further key findings from the study suggest:

  • Glucose testing segment dominated the market in 2013, accounting for over 29% of total revenue. High prevalence of diabetes coupled with the requirement of constant monitoring of blood sugar levels attribute to the aforementioned fact. According to statistics published by the International Diabetes Federation, the global prevalence of diabetes is expected to increase from 382 million in 2013 to 592 million in 2035, which is expected to have a positive impact on glucose testing demand.
  • The infectious disease testing is expected to be the fastest growing product segment, at an estimated CAGR of 16.2% from 2014 to 2020 with projected market revenue of USD 478.50 million in 2020.
  • Hospitals and clinics together constitute the largest revenue share of the Asia Pacific PoC market. Large volume of diagnostic tests performed in these healthcare facilities and the growing demand for decentralized point of care diagnostic facilities are two of the most important factors attributing to their large market shares. Clinics based PoC diagnostics market was valued at USD 1,104.51 million in 2013.
  • Japan dominated the Asia Pacific market in 2013, accounting for over 48% of total market revenue. However, the region is expected to lose market share by 2020, primarily due to faster growing markets such as India, Malaysia, Indonesia and China. China followed Japan in terms of revenue share in 2013 owing to the presence of high unmet medical needs coupled with constantly improving healthcare infrastructure.
  • Some of the key players of the Asia Pacific PoC diagnostics market include Roche Diagnostics, Alere Inc., Danaher Corporation, Abbott Laboratories, bioMerieux, Siemens Healthcare and others.

Request Sample of this Report @ http://www.grandviewresearch.com/request/332.

For the purpose of this study, Grand View Research has segmented the Asia Pacific PoC diagnostics market on the basis of product, application and region:

  •      Asia Pacific PoC Diagnostics Product Outlook
            • Blood Gas/Electrolytes
            • Infectious Diseases
            • Glucose Testing
            • Cardiac Markers
            • Hematology
            • Coagulation
            • Primary Care Systems (Includes Lipid and Hba1c tests)
            • Decentralized Clinical Chemistry
            • Urinalysis
            • Drug Abuse Testing
            • Fertility
            • OTC Diagnostics and Rapid Tests
            • Feces
  •      Asia Pacific PoC Diagnostics End-User Outlook
            • Hospitals
            • Laboratories
            • Assisted Living Healthcare Facilities
            • Home Healthcare
            • Clinics
            • Others
  •      Asia Pacific PoC Diagnostics Regional Outlook
            • India
            • Japan
            • China
            • Taiwan
            • Philippines
            • South Korea
            • Malaysia
            • Singapore
            • Indonesia
            • Australia
            • New Zealand
            • Hong Kong
            • Vietnam
            • Pakistan
            • Thailand
            • Rest of Asia Pacific

Latest Market Reports Published By Grand View Research:

Furandicarboxylic Acid (FDCA) Market Potential Analysis And Segment Forecasts To 2020 (http://www.grandviewresearch.com/industry-analysis/FDCA-Industry) The estimated market potential for FDCA is expected to reach USD 498.2 million by 2020, according to a new study by Grand View Research, Inc. Avantium’s FDCA production facility is expected to come online by in 2016 - 17 with annual capacity reaching 50 kilo tons by 2017. FDCA is expected to have great potential as a replacement to other petroleum based chemicals such as adipic acid, terephthalic acid and bisphenol A. The addressable market for FDCA as of 2013 was in excess of 50 million tons with PET and PBT being the largest applications.

Dental Equipment Market Analysis And Segment Forecasts To 2020 (http://www.grandviewresearch.com/industry-analysis/dental-equipment-market) The global dental equipment market is expected to reach USD 8,453.7 million by 2020, according to a new study by Grand View Research Inc. Growing demand for dental tourism in emerging Asian markets, increasing adoption rates of advance technologies such as CAD/CAM enabling expedited manufacturing of dental prosthetics and the presence of robust reimbursement frameworks in North America are expected to be primary growth drivers for the market over the next six years.

About Grand View Research

Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights. For more information, visit http://www.grandviewresearch.com.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058